Ribavirin plus interferon versus interferon for chronic hepatitis C

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Ribavirin plus interferon versus interferon for chronic hepatitis C. / Brok, Jesper; Gluud, Lise Lotte; Gluud, Christian.

In: Cochrane Database of Systematic Reviews, No. 1, 01.01.2010, p. CD005445.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Brok, J, Gluud, LL & Gluud, C 2010, 'Ribavirin plus interferon versus interferon for chronic hepatitis C', Cochrane Database of Systematic Reviews, no. 1, pp. CD005445. https://doi.org/10.1002/14651858.CD005445.pub2

APA

Brok, J., Gluud, L. L., & Gluud, C. (2010). Ribavirin plus interferon versus interferon for chronic hepatitis C. Cochrane Database of Systematic Reviews, (1), CD005445. https://doi.org/10.1002/14651858.CD005445.pub2

Vancouver

Brok J, Gluud LL, Gluud C. Ribavirin plus interferon versus interferon for chronic hepatitis C. Cochrane Database of Systematic Reviews. 2010 Jan 1;(1):CD005445. https://doi.org/10.1002/14651858.CD005445.pub2

Author

Brok, Jesper ; Gluud, Lise Lotte ; Gluud, Christian. / Ribavirin plus interferon versus interferon for chronic hepatitis C. In: Cochrane Database of Systematic Reviews. 2010 ; No. 1. pp. CD005445.

Bibtex

@article{21efd9d5966548f5bd8e6253efd54064,
title = "Ribavirin plus interferon versus interferon for chronic hepatitis C",
abstract = "Hepatitis C is a major cause of liver-related morbidity and mortality. Standard therapy is ribavirin plus pegylated interferon to achieve undetectable level of virus in the blood, but the effect on clinical outcomes is controversial.",
author = "Jesper Brok and Gluud, {Lise Lotte} and Christian Gluud",
year = "2010",
month = jan,
day = "1",
doi = "http://dx.doi.org/10.1002/14651858.CD005445.pub2",
language = "English",
pages = "CD005445",
journal = "Cochrane Database of Systematic Reviews",
issn = "1361-6137",
publisher = "Wiley",
number = "1",

}

RIS

TY - JOUR

T1 - Ribavirin plus interferon versus interferon for chronic hepatitis C

AU - Brok, Jesper

AU - Gluud, Lise Lotte

AU - Gluud, Christian

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Hepatitis C is a major cause of liver-related morbidity and mortality. Standard therapy is ribavirin plus pegylated interferon to achieve undetectable level of virus in the blood, but the effect on clinical outcomes is controversial.

AB - Hepatitis C is a major cause of liver-related morbidity and mortality. Standard therapy is ribavirin plus pegylated interferon to achieve undetectable level of virus in the blood, but the effect on clinical outcomes is controversial.

U2 - http://dx.doi.org/10.1002/14651858.CD005445.pub2

DO - http://dx.doi.org/10.1002/14651858.CD005445.pub2

M3 - Journal article

SP - CD005445

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1361-6137

IS - 1

ER -

ID: 34044493